Content about Maryland

August 13, 2012

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

SILVER SPRING, Md. — Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

The Food and Drug Administration approved Lucentis (ranibizumab) for diabetic macular edema, a cause of vision loss in people with diabetes. The drug already was approved for age-related macular degeneration.

August 10, 2012

Konsyl recently announced that nutrition expert Keri Glassman will become the company’s new spokeswoman.

EASTON, Md. — Konsyl recently announced that nutrition expert Keri Glassman will become the company’s new spokeswoman.

“Many people believe that fiber supplements are for people who already have health issues, but my goal is to show people that this is not the case,” Glassman said. “In fact, getting adequate amounts of fiber is necessary to everyone in order to best manage all aspects of well-being.”

August 9, 2012

The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.

The FDA approved South San Francisco, Calif.-based Talon Therapeutics' Marqibo (vincristine sulfate liposome), an injectable drug for Philadelphia chromosome-negative acute lymphoblasic leukemia, or Ph-negative ALL.

August 8, 2012

M-Edge is gearing up for back to school with its latest items.

ODENTON, Md. — M-Edge is gearing up for back to school with its latest items.

The company said its SuperStylus, which retails for $19.99, is a wide-grip stylus features an ergonomic grip and precise touch to make using a touchscreen device easy for students of any age, the company said. Also new is the SuperShell series of cases that are made with ultra-protective closed-cell foam and high-impact corners and are compatible with such devices as iPhone 4/4S, iPad 2 and 3, and Kindle Fire. The series carries a suggested retail price range from $29.99 to $34.99.

August 8, 2012

Procter & Gamble’s CoverGirl has partnered with musician P!nk, who recently wrapped her first print advertising campaign with the brand, which will debut in the fall.

HUNT VALLEY, Md. — Procter & Gamble’s CoverGirl has partnered with musician P!nk, who recently wrapped her first print advertising campaign with the brand, which will debut in the fall.

August 6, 2012

The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

The FDA announced the approval of montelukast sodium, a drug indicated for controlling asthma symptoms and relieving indoor and outdoor allergies.

The drug is a generic version of Merck's Singulair, which had sales of $4.6 billion in 2011, according to IMS Health.

August 6, 2012

The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

August 3, 2012

Harris Teeter plans to expand its presence in existing markets, the company said in its third-quarter earnings release.

MATTHEWS, N.C. — Harris Teeter plans to expand its presence in existing markets, the company said in its third-quarter earnings release.

August 3, 2012

AstraZeneca's biologics division has begun shipping doses of influenza vaccine to distributors for the 2012-2013 flu season, the company said.

GAITHERSBURG, Md. — AstraZeneca's biologics division has begun shipping doses of influenza vaccine to distributors for the 2012-2013 flu season, the company said.

August 3, 2012

Old Bay has partnered with a smartphone and tablet application Blippar to offer consumers a new way to experience the brand.

SPARKS, Md. — Old Bay has partnered with a smartphone and tablet application Blippar to offer consumers a new way to experience the brand.

Old Bay said when consumers download Blippar and "blip" Old Bay logos and packaging, it gives consumers access to 3-D interactive games, including Whack-A-Crab and Duckpin Bowling, as well as Old Bay recipes, such as snack mix, crispy wings, shrimp scampi and more. The brand's launch of Blippar marks the first use of this technology in the U.S. consumer products sector.

July 27, 2012

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

SILVER SPRING, Md. — A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 27, 2012

Save-A-Lot, a hard-discount, limited-assortment grocery chain and a wholly owned subsidiary of Supervalu, kicked off its 2012 Fuel Your Family Road Trip in Orlando to raise awareness of Save-A-Lot stores as the go-to destination for affordable food.

ST. LOUIS — Save-A-Lot, a hard-discount, limited-assortment grocery chain and a wholly owned subsidiary of Supervalu, kicked off its 2012 Fuel Your Family Road Trip in Orlando to raise awareness of Save-A-Lot stores as the go-to destination for affordable food.

July 24, 2012

The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

The FDA announced the approval of Tudorza Pressair (aclidinium bromide) for the long-term maintenance of COPD-related narrowing of the airways in the lung, also known as bronchospasm. The drug is an inhaled dry powder used twice per day.

July 23, 2012

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

July 18, 2012

The Food and Drug Administration has approved a new weight-loss drug made by Vivus, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new weight-loss drug made by Vivus, the agency said.

The FDA announced the approval of Qsymia (phentermine and topiramate) extended-release, designed for use by overweight and obese adults alongside a reduced-calorie diet and exercise for chronic weight management. The drug's original brand name was Qnexa.

July 16, 2012

The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

July 13, 2012

The main office of the Food and Drug Administration in charge of regulating generic drugs has appointed a new director, the agency said Friday.

SILVER SPRING, Md. — The main office of the Food and Drug Administration in charge of regulating generic drugs has appointed a new director, the agency said Friday.

The FDA announced the appointment of Gregory Geba as director of the Office of Generic Drugs, replacing acting director Keith Webber, effective Sunday.

Geba has served in various senior-level clinical and managerial positions in the drug industry for the past 15 years, most recently as deputy chief medical officer for Sanofi US, a subsidiary of French drug maker Sanofi.

July 6, 2012

Several intertwined factors are fueling the mass nail care market, and according to a new report by Packaged Facts, the growth of do-it-yourself nail products is expected to continue despite an uptick in professional nail services.

ROCKVILLE, Md. — Several intertwined factors are fueling the mass nail care market, and according to a new report by Packaged Facts, the growth of do-it-yourself nail products is expected to continue despite an uptick in professional nail services.

SymphonyIRI Group, a Chicago-based market research firm, reported that sales of nail care products grew 26% for the 52 weeks ended April 15 at food, drug and mass (excluding Walmart). Nail polish sales, in particular, grew about 43% during that time.

July 5, 2012

The Food and Drug Administration is asking companies to stop manufacturing and distributing unapproved drugs containing the painkiller oxycodone, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration is asking companies to stop manufacturing and distributing unapproved drugs containing the painkiller oxycodone, the agency said Thursday.

July 3, 2012

The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

The FDA announced the approval of the OraQuick In-Home HIV Test, calling it the first OTC, self-administered HIV test kit that detects the presence of antibodies to HIV, including the HIV-1 and HIV-2 strains.

June 28, 2012

The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

The FDA announced the approval of Myrbetriq (mirabegron), which works by relaxing the bladder muscle while the organ is filling. In patients with overactive bladder, the muscle can't be controlled, squeezes too often or squeezes without warning. Symptoms of overactive bladder include the need to urinate too often, the need to urinate immediately and incontinence. The condition affects about 33 million Americans.

June 27, 2012

The Food and Drug Administration has approved a new treatment for obesity in adults, the agency said Wednesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for obesity in adults, the agency said Wednesday.

The FDA announced the approval of Arena Pharmaceuticals' Belviq (lorcaserin hydrochloride), designed for use alongside reduced-calorie diets and exercise, for chronic weight management. Eisai will distribute the drug.

June 26, 2012

The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

ROCKVILLE, Md. — The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

Supernus announced the tentative approval was given to Trokendi XR (topiramate), a once-daily treatment for the seizure disorder. The company said final approval was conditioned on resolution of market exclusivity issues concerning certain pediatric populations.

June 19, 2012

The market for health and beauty care products targeted to minorities continues to advance at a healthy pace, and marketers should be ramping up in new products and marketing campaigns sooner rather than later, according to a new report released from Packaged Facts.

ROCKVILLE, Md. — The market for health and beauty care products targeted to minorities continues to advance at a healthy pace, and marketers should be ramping up in new products and marketing campaigns sooner rather than later, according to a new report released from Packaged Facts.

According to the "Ethnic Hair, Skin and Cosmetic Products in the U.S." report, the market posted growth of nearly 13% during 2010, and the market continued to advance at a healthy pace in 2011 to approach $3 billion.

June 19, 2012

Weis Markets on Tuesday reported its Paws for Pets program generated $191,000 in donations and pet supplies for 94 local animal shelters and rescue organizations in its five-state market area, nearly double the total raised in 2011.

SUNBURY, Pa. — Weis Markets on Tuesday reported its Paws for Pets program generated $191,000 in donations and pet supplies for 94 local animal shelters and rescue organizations in its five-state market area, nearly double the total raised in 2011.

The four-week program ran through Memorial Day weekend in the company's stores in Pennsylvania, Maryland, New Jersey, New York and West Virginia. During this time, 64 stores also hosted pet adopt-a-thon events with local pet organizations.